BRPI1007505A2 - derivado de tetraidronaftaleno-2-ol, e, uso do mesmo. - Google Patents
derivado de tetraidronaftaleno-2-ol, e, uso do mesmo.Info
- Publication number
- BRPI1007505A2 BRPI1007505A2 BRPI1007505A BRPI1007505A BRPI1007505A2 BR PI1007505 A2 BRPI1007505 A2 BR PI1007505A2 BR PI1007505 A BRPI1007505 A BR PI1007505A BR PI1007505 A BRPI1007505 A BR PI1007505A BR PI1007505 A2 BRPI1007505 A2 BR PI1007505A2
- Authority
- BR
- Brazil
- Prior art keywords
- tetrahydronaphthalene
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/42—Halogenated derivatives containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/21—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09155076 | 2009-03-13 | ||
| PCT/EP2010/053167 WO2010103095A1 (en) | 2009-03-13 | 2010-03-12 | Tetrahydronaphthalen-2-ol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1007505A2 true BRPI1007505A2 (pt) | 2016-02-23 |
Family
ID=40886684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007505A BRPI1007505A2 (pt) | 2009-03-13 | 2010-03-12 | derivado de tetraidronaftaleno-2-ol, e, uso do mesmo. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2406206B1 (pt) |
| JP (1) | JP5570535B2 (pt) |
| KR (1) | KR20110128790A (pt) |
| CN (1) | CN102272081B (pt) |
| AR (1) | AR075740A1 (pt) |
| AU (1) | AU2010223209B2 (pt) |
| BR (1) | BRPI1007505A2 (pt) |
| CA (1) | CA2748963C (pt) |
| ES (1) | ES2404344T3 (pt) |
| IL (1) | IL213262A0 (pt) |
| MX (1) | MX2011008868A (pt) |
| NZ (1) | NZ594085A (pt) |
| TW (1) | TW201043595A (pt) |
| WO (1) | WO2010103095A1 (pt) |
| ZA (1) | ZA201104279B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110746392B (zh) * | 2019-10-31 | 2023-06-09 | 重庆医科大学 | 一类呋喃化合物在制备抗肿瘤药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT388631B (de) | 1985-04-16 | 1989-08-10 | Siemens Ag Oesterreich | Einrichtung zur steuerung des feldstromes von gleichstrommotoren |
| PA8471201A1 (es) * | 1998-06-16 | 2000-09-29 | Pfizer Prod Inc | Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea |
| CO5271709A1 (es) * | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos |
| EP1282615B1 (en) * | 2000-03-01 | 2011-10-19 | N.V. Organon | Chroman derivatives as estrogenic compounds |
| CA2405070A1 (en) * | 2000-04-07 | 2001-10-18 | Pfizer Products Inc. | Estrogen agonist/antagonist metabolites |
| AU781168B2 (en) * | 2001-01-26 | 2005-05-12 | Pfizer Products Inc. | Method of treating certain cancers using an estrogen agonist/antagonist |
| ATE362471T1 (de) | 2001-11-19 | 2007-06-15 | Lilly Co Eli | Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta |
| US8093302B2 (en) * | 2005-02-15 | 2012-01-10 | Eli Lilly And Company | Substituted tetralins as selective estrogen receptor-β agonists |
| CN101092363B (zh) * | 2006-06-23 | 2010-08-18 | 浙江海正药业股份有限公司 | 芳基四氢萘类木脂素化合物及其制备方法和用途 |
-
2010
- 2010-02-25 TW TW099105514A patent/TW201043595A/zh unknown
- 2010-03-11 AR ARP100100744A patent/AR075740A1/es unknown
- 2010-03-12 ES ES10708535T patent/ES2404344T3/es active Active
- 2010-03-12 JP JP2011553464A patent/JP5570535B2/ja not_active Expired - Fee Related
- 2010-03-12 CN CN201080004282.2A patent/CN102272081B/zh not_active Expired - Fee Related
- 2010-03-12 AU AU2010223209A patent/AU2010223209B2/en not_active Ceased
- 2010-03-12 NZ NZ594085A patent/NZ594085A/xx not_active IP Right Cessation
- 2010-03-12 CA CA2748963A patent/CA2748963C/en active Active
- 2010-03-12 MX MX2011008868A patent/MX2011008868A/es not_active Application Discontinuation
- 2010-03-12 EP EP10708535A patent/EP2406206B1/en active Active
- 2010-03-12 WO PCT/EP2010/053167 patent/WO2010103095A1/en active Application Filing
- 2010-03-12 KR KR1020117013749A patent/KR20110128790A/ko not_active Application Discontinuation
- 2010-03-12 BR BRPI1007505A patent/BRPI1007505A2/pt not_active Application Discontinuation
-
2011
- 2011-05-31 IL IL213262A patent/IL213262A0/en unknown
- 2011-06-08 ZA ZA2011/04279A patent/ZA201104279B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201104279B (en) | 2012-02-29 |
| AR075740A1 (es) | 2011-04-20 |
| KR20110128790A (ko) | 2011-11-30 |
| CN102272081B (zh) | 2014-04-30 |
| WO2010103095A1 (en) | 2010-09-16 |
| NZ594085A (en) | 2013-01-25 |
| TW201043595A (en) | 2010-12-16 |
| CA2748963C (en) | 2017-03-28 |
| AU2010223209A1 (en) | 2011-06-30 |
| JP2012520265A (ja) | 2012-09-06 |
| EP2406206B1 (en) | 2013-01-30 |
| EP2406206A1 (en) | 2012-01-18 |
| MX2011008868A (es) | 2011-09-15 |
| JP5570535B2 (ja) | 2014-08-13 |
| CA2748963A1 (en) | 2010-09-16 |
| IL213262A0 (en) | 2011-07-31 |
| ES2404344T3 (es) | 2013-05-27 |
| AU2010223209B2 (en) | 2014-07-24 |
| CN102272081A (zh) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012002349A2 (pt) | composto,e, uso do mesmo | |
| BRPI1012861A2 (pt) | catalisador, e, uso do catalisador | |
| NO2021006I1 (no) | Quofenix, delafloksacin | |
| BRPI0821276A2 (pt) | Produto, e, uso do produto | |
| BRPI1016117A8 (pt) | derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
| BRPI0918122A2 (pt) | molécula de diaboy, diaboy, e mólecula dart | |
| BRPI0922391A2 (pt) | pneumático. | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| BRPI0920953A2 (pt) | dispositivo de manutenção, e uso do mesmo. | |
| BR112012005736A2 (pt) | di-hidro benzocicloalquiloximetil oxazolapirimidinonas substituídas, preparação e uso das mesmas | |
| UY33125A (es) | Diaza-espiro-[5,5]-undecanos | |
| BRPI0923418A2 (pt) | pneumático. | |
| BRPI1007811A2 (pt) | nacela de turborreator, e, turborreator | |
| BRPI0917446A2 (pt) | derivados de acilaminobenzamida. | |
| BRPI1006996A2 (pt) | composição, método e uso | |
| BRPI0913175A2 (pt) | artigo antibalístico, e, uso do mesmo. | |
| BRPI0818641A2 (pt) | Rótulo, e, uso do rótulo | |
| BRPI1016192A2 (pt) | derivados de soxazol. | |
| DK2442870T3 (da) | Pyrazinooxazepin-derivater. | |
| IT1396487B1 (it) | Convogliatore. | |
| BRPI1011036A2 (pt) | uso | |
| BRPI0923387A2 (pt) | pneumático. | |
| BRPI0816679A2 (pt) | Derivados de ftalazinona. | |
| BR112012000565A2 (pt) | ensaio de vírus. | |
| BRPI0924638A2 (pt) | ativação de função. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |